Related content

T-cell therapy targeting stromal cells may improve treatment of solid tumors

By  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 145-147

Future Medicine

Access to resources Recommend Favorite

Responses of T cells to ligands for the T-cell receptor

By Janeway Jr C.A.   Bottomly K.  

Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. : 109-115

Academic Press

Access to resources Recommend Favorite

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease

By Gu Tao   Kilinc Mehmet   Egilmez Nejat  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 997-1005

Springer Publishing Company

Access to resources Recommend Favorite

Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors

By                

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2099-2105

Spandidos Publications

Access to resources Recommend Favorite